# NAPOLI-1 (NCT01494506)

> Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01494506
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Merrimack Pharmaceuticals
- Conditions: Metastatic Pancreatic Cancer
- Interventions: MM-398; 5 Fluorouracil; Leucovorin
- Enrollment: 417
- Primary outcome: Overall Survival

## Commentary we found

- YouTube: 16
- Podcasts: 16
- X threads: 7

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=napoli-1-nct01494506

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01494506", "email": "<work email>"}; the inbox owner confirms by the emailed link.